XVIVO Update: Temporary growth dip and structural progress - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

XVIVO Update: Temporary growth dip and structural progress - Redeye

{newsItem.title}

Q1 is spot on expectations in most aspects. The organic CER growth of 14% is expected to improve with higher delivery capacity and solid demand for the core business. Later in 2025 and over the next three years, XVIVO is also in a good position to benefit from increasing launch support. XVIVO continues to invest in sustainable growth, including a higher inventory level and commercial capacity, in 2025, ahead of substantial launch support.

Länk till analysen i sin helhet: https://www.redeye.se/research/1097695/xvivo-update-temporary-growth-dip-and-structural-progress?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Om aktien Xvivo Perfusion

Senaste nytt